Click to Enlarge
Facebook
Twitter
Europe’s deepening vaccine “woes” make the Financial Times’s splash, after Brussels warned that supplies from pharmaceutical firm AstraZeneca would fall short in the first quarter. The paper says it comes on top of several EU countries suspending use of the jab over bloodclot fears and what the paper says are fading hopes that the US will provide extra doses.

Financial Times Front Page 21st of April 2026

Starmer says officials deliberately withheld information about Mandelson’s vetting before his proposed posting to Washington. He faced a tough Commons session, ordered an inquiry, and the sacked FCDO chief will testify, amid unease on Labour’s benches.

Read More »

Financial Times Front Page 20th of April 2026

Economists warn tensions centred on Iran will push up energy and shipping costs, keeping US inflation high even after conditions ease. Dearer petrol and insurance on key sea lanes could slow growth, strain household budgets and complicate the Fed’s stance into election season.

Read More »

Financial Times Front Page 18th of April 2026

Starmer stands firm amid a vetting row, blaming the Foreign Office for mishandled checks linked to a proposed role for Lord Mandelson. He will address MPs, aims to tighten procedures and resists calls to reverse course as unease rises within Labour.

Read More »

Financial Times Front Page 17th of April 2026

Keir Starmer faces claims he misled MPs after it emerged Lord Mandelson was blocked by security vetting for a planned US role. No 10 says ministers were unaware. Opponents demand the release of vetting advice and warn that, if the PM knew and denied it, he should resign.

Read More »